3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
10
Breast Neoplasms
5
Pain
4
Agnosia
3
Rectal Neoplasms
2
Lung Neoplasms
2
Leiomyoma
2
Colonic Neoplasms
2
post laminectomy syndrome
1
Uterine Cervical Dysplasia
1
Upper Abdominal Cancer Surgery
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Myoma
1
Lymphedema
1
Kidney Neoplasms
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Hot Flashes
1
Hemorrhage
1
Head and Neck Neoplasms
1
Gynecologic Surgical Procedures
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Failed Back Surgery Syndrome
1
Diverticulosis, Colonic
1
Interventions
Infliximab
2
vedolizumab
1
golimumab
1
Soybean Oil
1
Papillomavirus Vaccines
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fish Oils
1
Calcium Dobesilate
1
CT-P13
1
Bupivacaine
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Crohn Disease
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts